Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Marksans Pharma Limited ( (IN:MARKSANS) ) has issued an announcement.
Marksans Pharma Limited has announced an addendum to the notice of its 33rd Annual General Meeting, as published in the Business Standard and Lakshadeep newspapers. This announcement is part of the company’s compliance with regulatory requirements, reflecting its commitment to transparency and effective communication with stakeholders.
More about Marksans Pharma Limited
Marksans Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company primarily serves the global market with a variety of generic drugs and over-the-counter medications.
Average Trading Volume: 98,784
Technical Sentiment Signal: Buy
Current Market Cap: 103.3B INR
For an in-depth examination of MARKSANS stock, go to TipRanks’ Overview page.